TET: Lowered Price View Will Focus On Takeover Offer Downside Risk

Analysts have reduced their price target on Treatt by £0.35, reflecting updated views on revenue growth, profit margins, discount rates and future P/E assumptions.

What's in the News

Döhler Finance Management B.V. agreed to acquire the remaining 72.10% stake in Treatt plc for approximately £130 million in cash, valuing the offer at £3.05 per share, funded from existing cash resources of the Döhler Group. Source: M&A Transaction Announcements, April 29, 2026.
The acquisition is subject to antitrust clearance, court approval, and approval of the merger agreement and offer by both the acquirer and Treatt shareholders. The deal has been unanimously approved by Treatt's board. Expected completion is between July 1, 2026 and September 30, 2026. Source: M&A Transaction Announcements.
Schroder Investment Management Limited issued a non binding letter of intent indicating support for the acquisition for its Treatt shares where it has voting discretion, while disposing of part of its holding in early May 2026. Source: M&A Transaction Announcements.
Treatt's board decided not to declare an interim dividend for the six months ended March 31, 2026 in light of Döhler's offer. A final dividend of 3.00 pence per share for the year ended September 30, 2025 was previously approved at the March 26, 2026 AGM and will be accounted for in the second half of the 2026 financial year. Source: Dividend Decreases.
If the acquisition becomes effective, Treatt shares are expected to be delisted from the Official List and the Main Market of the London Stock Exchange. The company would then be re registered as a private limited company and the transaction would be effected via a court sanctioned scheme of arrangement under Part 26 of the Companies Act 2006. Source: Delistings.
A special or extraordinary shareholders meeting is scheduled for June 9, 2026 at the offices of Ashurst LLP in London, giving shareholders a formal forum to consider the proposed acquisition and related matters. Source: Special/Extraordinary Shareholders Meeting.

Valuation Changes

Fair Value: updated slightly from £2.34 to £2.36 per share, reflecting a modest adjustment in the modelled valuation.
Discount Rate: reduced from 7.64% to 7.53%, indicating a small change in the assessed risk profile used in the valuation work.
Revenue Growth: assumption increased from 3.63% to 5.61%, indicating higher expected revenue growth in the updated model.
Net Profit Margin: assumption raised from 5.70% to 7.10%, indicating a higher projected profitability level than before.
Future P/E: adjusted from 18.39x to 16.43x, indicating a lower multiple being applied to Treatt's expected earnings in the latest assessment.

5 views

Key Takeaways

Expansion into Asian markets and focusing on premium products is driving revenue growth and higher margins with low-cost strategies.
Customer-centric approaches and leveraging existing capacity enable scalable growth, reinforcing operational efficiency and boosting earnings.
Global expansion plans and dependence on limited key customers pose risks, with margin pressures from high citrus costs and growth challenges in premium segments.

Catalysts

About Treatt

Manufactures and supplies various natural extracts and ingredients to beverage, flavor, fragrance, and consumer goods markets in the United Kingdom, Germany, Ireland, rest of Europe, the United States, rest of the Americas, China, and internationally.What are the underlying business or industry changes driving this perspective?

Expansion into fast-growing Asian markets through distribution agreements is expected to drive revenue growth by accessing new geographies with low-cost, low-risk strategies, enhancing Treatt's global reach and top-line potential.
Increased focus on accelerating development and commercialization of premium products, particularly in tea and sugar reduction segments, aims to improve net margins by tapping into higher-value categories and leveraging existing technological expertise.
A shift towards a more customer-centric approach, including decentralized sales and marketing teams closer to key markets in Europe and North America, is anticipated to boost earnings by strengthening customer relationships and enabling faster go-to-market strategies.
Strategic plans to leverage Treatt’s existing capacity, with current utilization at 50% in the UK and 70% in the US, will allow for scalable growth without significant additional capital expenditure, enhancing operational efficiency and profit margins.
Sustained investment in innovations such as pilot equipment for premium product trials in North America is designed to increase the win rate of new business opportunities, thereby driving future sales growth and improving overall financial performance.

Treatt Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Treatt's revenue will grow by 5.6% annually over the next 3 years.
Analysts assume that profit margins will increase from 3.4% today to 7.1% in 3 years time.
Analysts expect earnings to reach £10.7 million (and earnings per share of £0.15) by about June 2029, up from £4.3 million today.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 16.6x on those 2029 earnings, down from 41.2x today. This future PE is lower than the current PE for the GB Chemicals industry at 25.5x.
Analysts expect the number of shares outstanding to grow by 0.6% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 7.53%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

Global expansion ambitions, such as entry into Southeast Asia and other new markets through distributors, could face execution risks and cultural challenges, potentially impacting future revenues if not managed effectively.
Relatively low growth in the premium segment at only 3% expansion and consumer downtrading in fruit and vegetable flavors indicate vulnerability to competitive pressures and market shifts, potentially affecting profit margins.
Concerns regarding high citrus raw material prices and their impact on gross margins, especially since citrus is a key component within the company, could result in margin volatility and affect net earnings.
Dependence on a concentrated top 10 customer base for revenue generation might limit diversification, posing a risk if these key relationships weaken or market preferences shift unpredictably.
Investment in new geographies, such as the innovation center in China, introduces risks like regulatory challenges, and uncertain political landscapes, which might affect operations and expected returns, impacting overall earnings predictions.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of £2.36 for Treatt based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of £2.7, and the most bearish reporting a price target of just £2.15.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be £151.1 million, earnings will come to £10.7 million, and it would be trading on a PE ratio of 16.6x, assuming you use a discount rate of 7.5%.
Given the current share price of £3.02, the analyst price target of £2.36 is 27.5% lower. Despite analysts expecting the underlying business to improve, they seem to believe the market's expectations are too high.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Treatt?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Expanding Into Asian Markets Will Strengthen Global Reach Through Low-Cost Strategies